Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Oncoimmunology|July 23, 2014
Immune response markers in sentinel nodes may predict melanoma progressionMonica Rodolfo, Chiara Castelli, Licia RivoltiniCancer Immunology, Immunotherapy : CII|August 17, 2004
A listing of human tumor antigens recognized by T cells: March 2004 updateLuisa Novellino, Chiara Castelli, Giorgio ParmianiMethods in Molecular Biology (Clifton, N.J.)|March 13, 2014
Monitoring the frequency and function of regulatory T cells and summary of the approaches currently used to inhibit regulatory T cells in cancer patientsChiara Camisaschi, Marcella Tazzari, Licia Rivoltini, et al.Oncoimmunology|May 6, 2015
Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunityChiara Castelli, Frédéric Triebel, Licia Rivoltini, et al.Current Opinion in Oncology|February 3, 2007
Melanoma immunology: past, present and futureGiorgio Parmiani, Chiara Castelli, Mario Santinami, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
Unique human tumor antigens: immunobiology and use in clinical trialsGiorgio Parmiani, Annamaria De Filippo, Luisa Novellino, et al.Critical Reviews in Oncology/Hematology|April 4, 2003
Immunology and immunotherapy of colorectal cancerPiero Dalerba, Cristina Maccalli, Chiara Casati, et al.Bio-Protocol|September 20, 2021
Melanoma Stem Cell Sphere Formation AssayAlessandra Tuccitto, Valeria Beretta, Francesca Rini, et al.Expert Review of Molecular Diagnostics|June 11, 2014
Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatmentChiara Camisaschi, Viviana Vallacchi, Chiara Castelli, et al.Cancer Immunity|May 16, 2003
T-cell response to unique and shared antigens and vaccination of cancer patientsGiorgio Parmiani, Marialuisa Sensi, Chiara Castelli, et al.Pageof 8